Physical & Mental Side Effects of Amphetamines: Short & Long-Term

Most patients I see who have been using amphetamines for six months or longer come in convinced their mental health problems started independently of the drug. The anxiety, the paranoia, the emotional flatness, they attribute it to stress, to their job, to relationships. In almost every case, the timeline tells a different story. The amphetamine came first. Understanding that sequence changes everything about how we treat it.

How Amphetamines Work in the Brain and Body

Amphetamines force three monoamine transporters to run in reverse. Normally, transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT) pull these neurotransmitters back into the neuron after they have done their job. Amphetamine hijacks those transporters and runs them backwards, flooding the synapse with dopamine, norepinephrine, and serotonin simultaneously.

Dopamine is what produces the euphoria and drives compulsive redosing. Norepinephrine is what raises your heart rate, blood pressure, and body temperature. Serotonin contributes to the mood elevation but also to appetite suppression and, in high doses, to hyperthermia.

Dextroamphetamine (d-amphetamine, sold as Dexedrine or as the active component of Adderall) has a stronger effect on dopamine and norepinephrine relative to serotonin than MDMA does. Methamphetamine takes this further still. The difference matters clinically because the cardiac and psychiatric risks scale with dopaminergic and noradrenergic load.

Short-Term Side Effects of Amphetamines

Short-term effects begin within 30 to 60 minutes of an oral dose and last 4 to 12 hours depending on the formulation. Extended-release versions (Adderall XR, Vyvanse) stretch this window to 10 to 14 hours, which extends side effect exposure.

Cardiovascular Effects

The norepinephrine surge is the most immediately dangerous short-term effect. Heart rate typically rises by 10 to 30 beats per minute. Systolic blood pressure can jump 10 to 20 mmHg at therapeutic doses and significantly higher with recreational use. In people with undiagnosed cardiac conditions, this is enough to trigger arrhythmia.

Vasoconstriction, the narrowing of blood vessels throughout the body, reduces blood flow to peripheral tissues. This is why hands and feet go cold and skin looks pale or mottled after a dose.

Central Nervous System Effects

Acutely, most people feel alert, focused, and confident. These are the effects that make amphetamines attractive and that justify their medical use in ADHD and narcolepsy.

The other side of this is that the same noradrenergic activation drives anxiety, restlessness, and jaw clenching (bruxism) in many users. At higher doses, the line between stimulation and agitation disappears. Tremor, headache, and insomnia are common even at prescribed doses.

Metabolic and Physical Short-Term Effects

Appetite suppression is near-universal. Amphetamines reduce ghrelin (the hunger hormone) and act centrally to suppress feeding behaviour. A single dose can eliminate appetite for 6 to 8 hours. Over time this produces significant weight loss, malnutrition, and immune suppression.

Dry mouth, nausea, and abdominal cramping occur in a significant minority of users. These are partly direct GI effects and partly consequences of the reduced blood flow to the gut.

Long-Term Side Effects of Amphetamines on the Brain

This is where the real damage accumulates. Short-term cardiovascular effects normalise when the drug wears off. Long-term neurological effects do not, at least not quickly.

Dopamine System Downregulation

Chronic amphetamine use triggers downregulation of dopamine D2 receptors. The brain responds to the constant dopamine flood by reducing the number of receptors available to receive it. The result is anhedonia, a clinical term for the inability to feel pleasure from things that used to feel rewarding.

Research using PET imaging has shown that heavy amphetamine users have significantly lower D2 receptor density in the striatum compared to controls. This is not a temporary state. Studies following former methamphetamine users show partial recovery over 12 to 24 months of abstinence, but some individuals show persistent deficits at two years.

This is the brain mechanism behind the flat, grey emotional landscape that patients describe after stopping. They are not depressed in the conventional sense. Their dopamine system physically cannot generate normal reward signals yet.

Serotonergic Damage

At recreational doses, d-amphetamine causes measurable serotonergic neurotoxicity. Animal studies show damage to serotonin axon terminals in the prefrontal cortex and hippocampus. In humans, cerebrospinal fluid levels of 5-HIAA (a serotonin metabolite) are lower in chronic amphetamine users, consistent with reduced serotonin synthesis or turnover.

This contributes to depression, impulsivity, and disrupted sleep architecture that persists well into abstinence.

Cognitive Effects of Long-Term Amphetamine Use

The pattern we see in clinic is that long-term users present with deficits in working memory, cognitive flexibility, and impulse control. These are frontal lobe functions, and they correspond to the areas most affected by prolonged dopaminergic and noradrenergic dysregulation.

Interestingly, ADHD patients taking prescribed dextroamphetamine at therapeutic doses do not show the same cognitive decline as recreational users. The difference is dose, frequency, and baseline neurological status. Therapeutic dosing improves cognition in ADHD by normalising underactive dopamine signalling. Recreational dosing overshoots that target repeatedly and causes neurotoxic oxidative stress.

Amphetamine-Induced Psychosis

Amphetamine-induced psychosis is clinically indistinguishable from acute schizophrenia. It includes paranoid delusions, auditory hallucinations, and thought disorganisation. It occurs because dopamine overactivation in the mesolimbic pathway, specifically the nucleus accumbens and ventral striatum, produces exactly the neurochemical state associated with psychotic symptoms.

It can occur after a single high dose. It becomes more likely with repeated use and sleep deprivation. In people with a genetic vulnerability to psychotic disorders, amphetamine use can trigger a psychotic episode that does not fully remit after the drug is cleared.

This is not a rare outcome. Studies suggest that 5 to 15% of chronic amphetamine users develop persistent psychotic symptoms. The risk is higher with methamphetamine than with d-amphetamine, but neither is safe.

Long-Term Physical Side Effects of Amphetamines

Cardiovascular Disease

Chronic amphetamine use accelerates cardiovascular disease through three mechanisms: sustained hypertension, direct catecholamine-mediated cardiac toxicity, and accelerated atherosclerosis. Long-term users have higher rates of left ventricular hypertrophy (the heart wall thickening from overwork), cardiomyopathy, and coronary artery disease than age-matched controls.

The risk of stroke and myocardial infarction is elevated even in young users with no other cardiac risk factors. The norepinephrine-driven vasoconstriction is the key mechanism here. It is not just about blood pressure numbers. It is about the chronic vascular stress.

Neurovascular Effects

Cerebral small vessel disease shows up on MRI in chronic heavy users at rates that would be expected in people 20 to 30 years older. Microbleeds and white matter hyperintensities are common findings. These are the structural substrate for the cognitive deficits described above.

Dental Destruction

Amphetamine-related dental decay, sometimes called “meth mouth” in its severe form but present across all amphetamine types, results from the combination of chronic dry mouth (xerostomia), bruxism, reduced saliva’s protective buffering of acid, poor nutrition, and often poor oral hygiene during active use. The decay is severe, rapid, and disproportionate to what would be expected from oral hygiene alone.

Immune Suppression and Weight Loss

Appetite suppression translates directly to malnutrition over months to years. Protein deficiency, vitamin deficiencies (particularly B vitamins and vitamin D), and chronic sleep deprivation all degrade immune function. Wound healing slows. Susceptibility to infection rises. Skin lesions from scratching (formication, the sensation of insects crawling under skin) become entry points for bacterial infection.

Amphetamine Side Effects in Specific Populations

Adolescents and Young Adults

The adolescent brain is still developing its prefrontal cortex until the mid-twenties. Amphetamine exposure during this window carries disproportionate risk for lasting cognitive effects and for accelerating the development of stimulant use disorder. The dopamine system is more plastic and more vulnerable. Early-onset use is one of the strongest predictors of persistent cognitive deficits in adulthood.

People with Co-Occurring Mental Health Conditions

If you have a personal or family history of bipolar disorder, schizophrenia, or any psychotic illness, amphetamines carry a categorically higher psychiatric risk. Even prescribed stimulants can destabilise mood or trigger a manic episode in someone with undiagnosed bipolar II disorder. This happens more often than most people expect.

Anxiety disorders are worsened by amphetamine use in the majority of cases, even when the person’s initial experience is positive. The long-term noradrenergic dysregulation sensitises the stress response system in ways that outlast the drug’s direct effects. The relationship between long-term stimulant overstimulation and lasting brain changes is worth understanding if you or someone you care about falls into this category.

People Using Other Substances

Combining amphetamines with alcohol masks the subjective intoxication of both substances, leading to higher consumption of each. The cardiovascular strain is additive. Combining with cocaine compounds dopamine and norepinephrine overload to a dangerous degree. Combining with any serotonergic drug (SSRIs, SNRIs, tramadol, MDMA) raises the risk of serotonin syndrome significantly.

Withdrawal and Comedown: What Happens When You Stop

When amphetamine clears the system, the dopamine and norepinephrine supply drops precipitously, but the receptors are still downregulated from chronic exposure. The result is a functional state of profound monoamine deficiency.

The acute comedown involves extreme fatigue, hypersomnia (sleeping 12 to 16 hours), increased appetite, depression, and irritability. This typically lasts 2 to 4 days.

The protracted withdrawal phase is more clinically significant. Dysphoria, anhedonia, cognitive fog, and strong drug cravings persist for weeks to months. There is no FDA-approved pharmacotherapy for amphetamine withdrawal specifically. Supportive care, sleep normalisation, and nutritional rehabilitation form the basis of clinical management. Bupropion has some evidence for reducing cravings in stimulant use disorder, though the effect size is modest.

Dextroamphetamine vs. Illicit Amphetamine: Are the Risks the Same?

The core molecular mechanism is identical. Dextroamphetamine prescribed for ADHD or narcolepsy acts on the same transporters (DAT, NET, SERT) as street amphetamine. The differences are dose, formulation, and frequency of use.

Therapeutic dextroamphetamine is taken in controlled doses, typically 5 to 40mg per day, and extended-release formulations produce a slower peak, which reduces the dopamine spike that drives compulsive use. Illicit amphetamine is taken in variable, often much larger doses, with irregular timing that maximises peaks and crashes.

That said, even prescribed dextroamphetamine carries real cardiovascular risk in patients with hypertension, structural heart disease, or a history of arrhythmia. The side effect profile is real regardless of the prescription pad.

For a more detailed look at how amphetamine and methamphetamine compare structurally and pharmacologically, the difference between amphetamine and methamphetamine is covered in depth separately.

Stimulant use disorder, as defined in DSM-5, is diagnosed when amphetamine use causes clinically significant impairment and the person continues despite consequences. The hallmarks are tolerance (needing more to get the same effect), withdrawal on stopping, failed attempts to cut down, and use that crowds out work, relationships, and health. Two or three of these criteria met in a 12-month period constitutes a mild disorder. Six or more constitutes severe. The Koob-Volkow model of addiction describes this progression as a shift from impulsive use driven by reward to compulsive use driven by the need to avoid withdrawal and dysphoria. By the time most patients reach treatment, they are in that second phase.

At Phuket Island Rehab, we work with people at every stage of stimulant use disorder. Residential treatment combines medically supervised stabilisation, structured psychiatric assessment, and individual and group therapy targeting the specific cognitive and mood effects of long-term stimulant use. If you are considering treatment for yourself or someone close to you, the amphetamine addiction treatment options available in Thailand are a practical starting point.

Amphetamines produce side effects across two timeframes that operate through different mechanisms. Short-term effects are driven largely by norepinephrine and dopamine flooding the peripheral and central nervous system at once: elevated heart rate, raised blood pressure, suppressed appetite, insomnia, and anxiety are the most common. At high doses, hyperthermia and cardiovascular crisis become genuine emergencies. Long-term effects reflect structural and neurochemical remodelling. D2 receptor downregulation, serotonin axon terminal damage, white matter changes, cardiomyopathy, and a persistent vulnerability to psychosis are documented consequences of sustained heavy use. Dextroamphetamine and illicit amphetamine share the same core toxicity profile. The dose and pattern of use determine how far along that spectrum any individual lands.

Practically, the most important things to understand are these. Psychiatric symptoms, paranoia, depression, emotional blunting, that appear during or after amphetamine use are drug-related until proven otherwise. Withdrawal carries a real suicide risk and should not be managed alone. Cognitive and emotional recovery takes longer than most people expect, often 12 to 24 months of abstinence before meaningful neurological recovery is measurable. For people using prescribed stimulants, the side effects are real and worth monitoring, not just tolerating. As John A. Smith of Phuket Island Rehab puts it: “The patients who do best are the ones who stop assuming the way they feel is just who they are now. The brain changes are real, but so is the recovery. The hardest part is giving it enough time.”

What are the most common side effects of dextroamphetamine?

The most common side effects of dextroamphetamine are insomnia, decreased appetite, elevated heart rate, dry mouth, and anxiety. These occur because dextroamphetamine causes a simultaneous release of dopamine, norepinephrine, and serotonin in the brain and body. At therapeutic doses, most of these are manageable. At higher doses or with prolonged use, the same effects become more severe and persistent.

Can amphetamines cause permanent brain damage?

Yes, heavy or prolonged amphetamine use can cause lasting brain changes, though “permanent” depends on dose, duration, and individual genetics. PET imaging studies show reduced dopamine D2 receptor density and serotonin transporter availability in long-term users. Partial recovery is well documented with sustained abstinence over 12 to 24 months, but some individuals show persistent deficits beyond that window, particularly in cognitive function and emotional regulation.

How long do the mental side effects of amphetamines last after stopping?

The acute crash lasts 2 to 4 days. The more clinically significant protracted withdrawal, including depression, anhedonia, cognitive fog, and cravings, typically persists for 4 to 12 weeks and sometimes longer. For heavy long-term users, meaningful neurological recovery on PET scan measures takes 12 to 24 months of full abstinence. Sleep normalisation usually occurs sooner, within weeks to a few months.

What is amphetamine-induced psychosis and who is at risk?

Amphetamine-induced psychosis is a state of paranoid delusions, hallucinations, and disorganised thinking caused by excessive dopamine activity in the mesolimbic pathway. It is clinically indistinguishable from acute schizophrenia and can occur after a single high dose or after repeated use. People with a personal or family history of psychotic illness, those who use high doses, and those who combine amphetamines with sleep deprivation face the highest risk. It resolves in most cases once the drug clears, but in a subset of users, psychotic symptoms persist.

Is it dangerous to take amphetamines with antidepressants?

It depends heavily on the antidepressant class. Combining amphetamines with MAOIs (monoamine oxidase inhibitors) is potentially fatal due to the risk of hypertensive crisis and serotonin syndrome. Combining with SSRIs or SNRIs raises serotonin levels further and increases serotonin syndrome risk, though the threshold is higher than with MAOIs. If you are prescribed both a stimulant and an antidepressant, your prescribing doctor needs to know about both medications. Never combine these without explicit medical guidance.

Do amphetamine side effects differ between prescribed use and recreational use?

The underlying pharmacology is identical, but the clinical risk profile differs substantially. Prescribed dextroamphetamine is taken at controlled doses with a slower-release formulation that blunts the dopamine peak driving compulsive use and neurotoxicity. Recreational use typically involves higher doses, irregular timing, and binge patterns that amplify every side effect. The cardiovascular, psychiatric, and neurological risks scale with dose and peak plasma concentration, not with whether a prescription exists.